SE430888B - OPTICALLY ACTIVE LEFT ROTATING N- (1-ETHYL-2-PYRROLIDINYL-METHYL) -2-METOXY-5-SULFAMOYL BENZAMIDE AND PROCEDURE TO PREPARE THIS - Google Patents

OPTICALLY ACTIVE LEFT ROTATING N- (1-ETHYL-2-PYRROLIDINYL-METHYL) -2-METOXY-5-SULFAMOYL BENZAMIDE AND PROCEDURE TO PREPARE THIS

Info

Publication number
SE430888B
SE430888B SE7901337A SE7901337A SE430888B SE 430888 B SE430888 B SE 430888B SE 7901337 A SE7901337 A SE 7901337A SE 7901337 A SE7901337 A SE 7901337A SE 430888 B SE430888 B SE 430888B
Authority
SE
Sweden
Prior art keywords
ethyl
levo
methoxy
pyrrolidinylmethyl
process according
Prior art date
Application number
SE7901337A
Other languages
Swedish (sv)
Other versions
SE7901337L (en
Inventor
F Mauri
Original Assignee
Ravizza Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ravizza Spa filed Critical Ravizza Spa
Publication of SE7901337L publication Critical patent/SE7901337L/en
Publication of SE430888B publication Critical patent/SE430888B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

15 20 25 30 35 7901337~1 2 toxicitet är även mycket lägre mot alla logiska förvänt- ningar. 15 20 25 30 35 7901337 ~ 1 2 toxicity is also much lower against all logical expectations.

Efter att ha bestämt den höga terapeutiska för- mågan hos vänsterroterande N-(l-etyl-2-pyrrolidinylmetyl)- -2-metoxi-5-sulfamoylbensamid framlades problemet med att separera racemisk Sulpiride innehållande denna genom en ekonomisk industriell process.After determining the high therapeutic capacity of left-rotating N- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy-5-sulfamoylbenzamide, the problem of separating racemic Sulpiride containing it was presented by an economical industrial process.

Emellertid har alla försök som gjorts för att upplösa racemisk Sulpiride antingen varit totalt nega- tiva eller har som mest lett endast till isolering av små mängder av den vänsterroterandeisomeren.However, all attempts to dissolve racemic Sulpiride have either been totally negative or have at most led to the isolation of only small amounts of the left-rotating isomer.

Det var därför absolut omöjligt att basera en industriell process på dessa upplösningsmetoder.It was therefore absolutely impossible to base an industrial process on these dissolution methods.

En industriell process'har nu utvecklats och utgör ändamålet med föreliggande uppfinning, vilken utgår från ett kommersiellt tillgängligt råmaterial med låg kostnad och möjliggör erhållandet av mycket ren vänster- roterandeN-(l-etyl-2-pyrrolidinylmetyl)-2~metoxi-5- -sulfamoylbensamid med mycket höga utbyten under an- vändning av ett mycket enkelt och ekonomiskt förfarande.An industrial process has now been developed and is the object of the present invention, which is based on a commercially available raw material at low cost and enables the obtaining of very pure left-rotating N- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy-5- -sulfamoylbenzamide in very high yields using a very simple and economical procedure.

Det nya förfarandet enligt föreliggande uppfinning representeras schematiskt med följande reaktionsschema: i-ïï 1) [ KN Com, KN C001* . I H (levo) fo CH3 (levo) 2) 1 '- d k 1 re u tion _ - kN/-coon , oN/-cazon ! I ?° ÉH2 CH3 (levo) CH3 (levo) 7901337-1 3 ) »m3 i . . ' klorerin ~ CH -Cl -å CH NH Mï/-cazofl ----9a \ 2 \N/' 2 2 b? .The novel process of the present invention is schematically represented by the following reaction scheme: i-ïï1) [KN Com, KN C001 *. I H (levo) fo CH3 (levo) 2) 1 '- d k 1 re u tion _ - kN / -coon, oN / -cazon! I? ° ÉH2 CH3 (levo) CH3 (levo) 7901337-1 3) »m3 i. . 'chlorine ~ CH -Cl -å CH NH Mï / -cazo fl ---- 9a \ 2 \ N /' 2 2 b? .

QR* ÉHZ (1 > çflz (levo) evo (levo) CH3 CH3 CH3 CO-OR 4) ' 1-1 { ~\ ocH3 N/*cnz - Nnz + Hzuozs ,/ ' ROH _ I _ CH2 1 (levo) CH3 CO - NH ” CH2 | ~_~ocn CH // I 3 ènz (levo) 3 I H2No2s flä/ 7961337 '-1 10 15 20 25 30 35 4 Man har i själva verket överraskande funnit att med utgångspunkt från vänsterroterandeprolin, som är en naturlig kommersiellt tillgänglig produkt till låg kostnad,är det möjligt att utsätta denna för en serie kemiska omvandlingar för att erhålla vänsterroterande N-etyl-2-aminometyl-pyrrolidin, utan att det blir någon racemisering eller invertering av produktens optiska aktivitet under processtegen.QR * ÉHZ (1> ç fl z (levo) evo (levo) CH3 CH3 CH3 CO-OR 4) '1-1 {~ \ ocH3 N / * cnz - Nnz + Hzuozs, /' ROH _ I _ CH2 1 (levo) CH3 CO - NH ”CH2 | ~ _ ~ ocn CH // I 3 ènz (levo) 3 I H2No2s fl ä / 7961337 '-1 10 15 20 25 30 35 4 It has in fact surprisingly been found that on the basis of left-rotating proline, which is a naturally commercially available product for low cost, it is possible to subject it to a series of chemical conversions to obtain left-rotating N-ethyl-2-aminomethyl-pyrrolidine, without any racemization or inversion of the optical activity of the product during the process steps.

Den som slutprodukt vid dessa kemiska omvandlingar av prolin erhållna vänsterroterandeN-etyl-2-aminometyl- -pyrrolidinen kan omsättas med en ester av 2-metoxi-5- esulfamoylbensoesyra under lämpliga betingelser för att ge N-(l-etYl-2*PYrrOlidinyl-metyl)-2-metoxi-5-sulfamoyl- bensamid vilket görs under ganska drastiska betingelser vad beträffar temperatur, tid och mekanisk homogeni- sering av massan, för att ge den slutliga vänsterroterande produkten med nästan kvantitativa utbyten. aNedan beskrivs i detalj de individuella stegen i förfarandet enligt föreliggande uppfinning: 1. Vänsterroterandeprolin acetyleras i lösning med ett lämpligt acetylerande ämne, såsom acetylklorid eller ättiksyraanhydrid. Acetyleringen genomföres före- trädesvis i en vattenlösning med ett stort överskott av ättiksyraanhydrid. Reaktionen är exoterm. Den vänsterroterandeacetylprolinen utfälles genom kylning och separeras genom filtrering. En mycket ren kris- tallin produkt erhålles med ett utbyte av ca 90 %. 2. Den vänsterroterandeacetylprolinen undergår reduktion med ett reducerande system, vilket verkar samtidigt under samma betingelser på acetyl- och karboxyl- grupperna. Goda resultat erhålles genom användning fav metallhydrider i ett organiskt lösningsmedel.The left-rotating N-ethyl-2-aminomethyl-pyrrolidine obtained as a final product in these chemical conversions of proline can be reacted with an ester of 2-methoxy-5-esulfamoylbenzoic acid under suitable conditions to give N- (1-ethyl-2 * PYrrOlidinyl). methyl) -2-methoxy-5-sulfamoylbenzamide which is done under rather drastic conditions in terms of temperature, time and mechanical homogenization of the pulp, to give the final left-rotating product with almost quantitative yields. The individual steps of the process of the present invention are described in detail below: 1. Left-rotating proline is acetylated in solution with a suitable acetylating agent, such as acetyl chloride or acetic anhydride. The acetylation is preferably carried out in an aqueous solution with a large excess of acetic anhydride. The reaction is exothermic. The left-rotating acetylproline is precipitated by cooling and separated by filtration. A very pure crystalline product is obtained with a yield of about 90%. The left-rotating acetylproline undergoes reduction with a reducing system, which acts simultaneously under the same conditions on the acetyl and carboxyl groups. Good results are obtained by using fav metal hydrides in an organic solvent.

Särskilt goda utbyten, ca 60 %, erhålles med LiAlH4 i tetrahydrofuran. Reduktionen genomföres under äter- flöde och produkten separeras genom utfällning av den oreagerade acetylprolinen ur reaktionsblandningen medelst en alkalisk bas. Den vänsterroterandeN>etyl- 10 15 20 25 30 35 7901337 -1 5 -2-pyrrolidinylmetanolen separeras från filtratet genom destillation under vakuum.Particularly good yields, about 60%, are obtained with LiAlH 4 in tetrahydrofuran. The reduction is carried out under reflux and the product is separated by precipitating the unreacted acetylproline from the reaction mixture by means of an alkaline base. The left-rotating ethyl acetate-2-pyrrolidinylmethanol is separated from the filtrate by distillation under vacuum.

Den vänsterroteranæaN-etyl-2-pyrrolidinylmetanolen omvandlas till den motsvarande 2-metylaminen genom att först ersätta hydroxylen med en aktiv kloratom och därefter omsätta kloriden med ammoniak. Klor- derivatet av alkoholen kan framställas med användning av vilket lämpligt reaktantsystem som helst.The left-hand rotanane N-ethyl-2-pyrrolidinylmethanol is converted to the corresponding 2-methylamine by first replacing the hydroxyl with an active chlorine atom and then reacting the chloride with ammonia. The chlorine derivative of the alcohol can be prepared using any suitable reactant system.

Företrädesvis genomföras reaktionen med tionylklorid i ett vattenfritt klorerat organiskt lösningsmedel, såsom CHCI3, CCI4, CH2Cl2, mellan omgivningens tem- peratur och 60°C. Tionylkloriden kan användas an- tingen i stökiometriskt förhållande eller i litet överskott. När reaktionen är avslutad elimineras lösningsmedlet och återstoden omsättes med en metanol- eller etanollösning av ammoniak vid omgivande temperatur.Preferably, the reaction is carried out with thionyl chloride in an anhydrous chlorinated organic solvent, such as CHCl 3, CCl 4, CH 2 Cl 2, between ambient temperature and 60 ° C. The thionyl chloride can be used either in a stoichiometric ratio or in a small excess. When the reaction is complete, the solvent is eliminated and the residue is reacted with a methanol or ethanol solution of ammonia at ambient temperature.

Den vänsterroteranmaN-etyl-2-aminometyl-pyrrolidinen, som har bildats, separeras, med utbyten av ca 50 %, genom eliminering av alkohollösningsmedlet, lösning i en alkalisk vattenlösning och extrahering från vattenlösningen genom ett lämpligt organiskt lösningsmedel, företrädesvis etyleter.The left-hand rotanan-N-ethyl-2-aminomethyl-pyrrolidine which has formed is separated, in yields of about 50%, by elimination of the alcohol solvent, solution in an alkaline aqueous solution and extraction from the aqueous solution by a suitable organic solvent, preferably ethyl ether.

Den vänsterroteramkeN-etyl-2-aminometyl-pyrrolidinen omsättes med en ester av 2-metoxi-5-sulfamoylbensoe- syra i frånvaro av lösningsmedel vid en temperatur av 80-90°C, vilken temperatur upprätthålls utan till- försel av yttre värme p g a reaktionens exoterma natur och med användning av blandning av reaktions- deltagarna i en Z-blandare, vilket är kritiskt och nödvändigt för att genomföra reaktionen (spanska patentskriften 428 341).The left rotary frame N-ethyl-2-aminomethyl-pyrrolidine is reacted with an ester of 2-methoxy-5-sulfamoylbenzoic acid in the absence of solvent at a temperature of 80-90 ° C, which temperature is maintained without the addition of external heat due to the reaction. exothermic nature and using mixing of the reactants in a Z-mixer, which is critical and necessary to carry out the reaction (Spanish Patent 428 341).

Mycket ren vänsterroteramàaN-(l-etyl-2-pyrrolidinyl- metyl)-2-metoxi-5-sulfamoylbensamid erhålles genom kristallisation ur reaktionsmassan med användning av ett lämpligt lösningsmedel, företrädesvis etanol, vilket ger utbyten av 90-95 %. 10 15 20 25 30 35 ?901337'1 6 Alternativt kan de ovan beskrivna stegen 3 och 4 c genomföras i följd i samma reaktor utan separation av aminmellanprodukten. I detta fallet blandas, efter eli- minering av alkoholen och oreagerad ammoniak genom in- dunstning, återstoden direkt med estern av 2-metoxi-5- -sulfamoylbensoesyran i frånvaro av lösningsmedel och med användning av en Z-blandare för blandningsändamålen.Very pure left-rotamanol- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy-5-sulfamoylbenzamide is obtained by crystallization from the reaction mass using a suitable solvent, preferably ethanol, to give yields of 90-95%. Alternatively, steps 3 and 4c described above can be performed sequentially in the same reactor without separation of the amine intermediate. In this case, after elimination of the alcohol and unreacted ammonia by evaporation, the residue is mixed directly with the ester of the 2-methoxy-5-sulfamoylbenzoic acid in the absence of solvent and using a Z-mixer for the mixing purposes.

Den vänstervridande N-(l-etyl-2-pyrrolidinylmety1)- -2-metoxi-5-sulfamoylbensamiden som erhålles genom för- farandet enligt föreliggande uppfinning har följande .egenskaper: smp = 186-l88°C (n.c.); [a_7š°° = -sa,s° 'cc = 1 s 1 nns-n renhet = 99,5 %; ' IR: se fig 1, vilken visar de ovanför varandra belägna spektra för produkten erhâllen genom förfarandet i fyra steg och genom förfarandet i tre steg.The left-handed N- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy-5-sulfamoylbenzamide obtained by the process of the present invention has the following properties: mp = 186-188 ° C (n.c.); [a_7š °° = -sa, s ° 'cc = 1 s 1 nns-n purity = 99.5%; IR: see Fig. 1, which shows the superimposed spectra of the product obtained by the four-step process and by the three-step process.

Tunnskiktskromatografi på silikagel 60 F 254: Elueringsmedel isopropanol:metanolzammoniak, koncentration s=1=1. ' Detektor: UV 254 eller Drägendorff.Thin layer chromatography on silica gel 60 F 254: Eluent isopropanol: methanol ammonia, concentration s = 1 = 1. 'Detector: UV 254 or Drägendorff.

Rf = approximativt 0,40.Rf = approximately 0.40.

Den nya produkten kan administreras oralt blandad med normala farmaceutiska spädmedel, såsom laktos, mag- nesiumstearat etc, för att bilda kapslar eller tabletter.The new product can be administered orally mixed with normal pharmaceutical diluents, such as lactose, magnesium stearate, etc., to form capsules or tablets.

Den kan även administreras parenteralt i vatten- lösning i form av ett salt, t ex ett sulfat.It can also be administered parenterally in aqueous solution in the form of a salt, for example a sulphate.

För att underlätta reproduktionen av förfarandet enligt föreliggande uppfinning beskrivs nedan en praktisk utföringsform medelst ett på inget sätt begränsande I exempel.In order to facilitate the reproduction of the method according to the present invention, a practical embodiment is described below by means of a non-limiting example.

EXEMEL l.Framställning av levo-N-acetyl-prolin. 11,5 kg levo-prolin löses i 30 liter vatten och 21,5 kg ättiksyraanhydrid tillsättes till lösningen under omröring. Temperaturen stiger spontant och bland- ningen får stå under omröring i ytterligare 20-30 min. 10 15 20 25 30 35 7901337-1 7 Reaktorn kyls därefter till en temperatur av 0-4°C och får stå tills den kristallina massan fullständigt sepa- rerar (ca 12 h). Den filtreras, fällningen tvättas med isvatten och torkas. Ytterligare lO kg av produkten utvinnes i moderluten efter tillsats av litet isopro- panol. Totalt erhålles 15 kg levo-N-acetyl-prolin som har en smältpunkt av 89°C med ett utbyte av 95 %.EXAMPLE 1. Preparation of levo-N-acetyl-proline. 11.5 kg of levoproline are dissolved in 30 liters of water and 21.5 kg of acetic anhydride are added to the solution with stirring. The temperature rises spontaneously and the mixture is allowed to stir for an additional 20-30 minutes. 10 15 20 25 30 35 7901337-1 7 The reactor is then cooled to a temperature of 0-4 ° C and allowed to stand until the crystalline mass completely separates (approx. 12 hours). It is filtered, the precipitate is washed with ice water and dried. An additional 10 kg of the product is recovered in the mother liquor after the addition of a little isopropanol. A total of 15 kg of levo-N-acetyl-proline is obtained which has a melting point of 89 ° C with a yield of 95%.

Procentuell analys: beräknat funnet C 53,49 53,35 H 7,06 7,00 N 8,90 8,95 2. Framställning av levo-N-etyl-2-pyrrolidinylmetano1. 15 kg N-acetyl-prolin sättes till en lösning inne- hållande 14,25 kg LiAlH4 i 500 liter tetrahydrofuran.Percent analysis: calculated found C 53.49 53.35 H 7.06 7.00 N 8.90 8.95 2. Preparation of levo-N-ethyl-2-pyrrolidinylmethanol. 15 kg of N-acetyl-proline are added to a solution containing 14.25 kg of LiAlH4 in 500 liters of tetrahydrofuran.

Lösningen uppvärmes under återflöde i 24 h.The solution is heated under reflux for 24 hours.

Efter denna tid kyls den till O°C och därefter tillsättes 100 liter tetrahydrofuran innehållande ca 4 % vatten och 12 liter 20 % Na0H. Den bildade fäll- ningen filtreras, tetrahydrofuranen indunstas och åter- stoden destilleras under vakuum. 9 kg N-etyl-2-pyrrolidinylmetanol erhålles, vilken har en kokpunkt av 80°C/16 mm, med ett utbyte av 75 %.After this time it is cooled to 0 ° C and then 100 liters of tetrahydrofuran containing about 4% water and 12 liters of 20% NaOH are added. The precipitate formed is filtered off, the tetrahydrofuran is evaporated and the residue is distilled under vacuum. 9 kg of N-ethyl-2-pyrrolidinylmethanol are obtained, which has a boiling point of 80 ° C / 16 mm, with a yield of 75%.

Procentuell analys: beräknat funnet C 65,07 64,95 H 11,70 ll,72 N 10,84 10,80 3. Framställning av levo-N-(l-etyl-2-pyrrolidinyl- metyl)-2-metoxi-5-sulfamoylbensamid. 9 kg levo-N-etyl-2-pyrrolidinylmetanol löses i 200 liter CH2Cl2 och 6 kg tionylklorid droppas ner i denna lösning under kalla betingelser. Lösningen omröres i 6 h vid omgivande temperatur och därefter i 2 h under kokning och indunstas till torrhet. Den oljiga återstoden upptas i etanol mättad med ammoniak och blandningen hålls under omröring vid omgivande temperatur i en natt. 10 15 20 25 30 7901 337--1 8 Alkoholen och ammoniaken indunstas därefter under vakuum. Återstoden upptas i litet vatten, NaOH droppas i och blandningen extraheras med etyleter. Eterfasen torkas och indunstas. Återstoden från indunstningen (ca 5 kg) tillsammans med 9 kg etyl-2-metoxi-5-sulfamoylbensoat matas in i en Z-blandare och blandningen uppvärmes till 85°C.Percent analysis: calculated found C 65.07 64.95 H 11.70 11.72 N 10.84 10.80 3. Preparation of levo-N- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy- 5-sulfamoylbenzamide. 9 kg of levo-N-ethyl-2-pyrrolidinylmethanol are dissolved in 200 liters of CH 2 Cl 2 and 6 kg of thionyl chloride are dropped into this solution under cold conditions. The solution is stirred for 6 hours at ambient temperature and then for 2 hours under boiling and evaporated to dryness. The oily residue is taken up in ethanol saturated with ammonia and the mixture is kept under stirring at ambient temperature for one night. The alcohol and ammonia are then evaporated in vacuo. The residue is taken up in a little water, NaOH is added dropwise and the mixture is extracted with ethyl ether. The ether phase is dried and evaporated. The residue from the evaporation (about 5 kg) together with 9 kg of ethyl 2-methoxy-5-sulfamoylbenzoate is fed into a Z-mixer and the mixture is heated to 85 ° C.

Efter en viss tid börjar ett kristallint pulver att separera från den flytande massan. Reaktionen är exoterm och temperaturen kvarhâlls spntant vid 80-8S°C utan någon ytterligare tillförsel av värme. Reaktionen är fullständig på 8 h.After a certain time, a crystalline powder begins to separate from the liquid mass. The reaction is exothermic and the temperature is maintained spontaneously at 80-8S ° C without any additional supply of heat. The reaction is complete in 8 hours.

Det erhållna pulvret löses under kalla betingelser i 400 liter vatten innehållande 4 liter koncentrerad klorvätesyra, lösningen filtreras och neutraliseras med natriumvätekarbonat. Det erhållna kristallina pulvret omkristalliseras ur etanol. ll kg levo-N-(l-etyl-2- ~pyrr0liåinylmetyl)-2-metoxi-5-sulfamoylbensamid erhålles med en renhet av 99,5 % och ett utbyte av 92 % beräknat på estern.The resulting powder is dissolved under cold conditions in 400 liters of water containing 4 liters of concentrated hydrochloric acid, the solution is filtered and neutralized with sodium bicarbonate. The resulting crystalline powder is recrystallized from ethanol. 11 kg of levo-N- (1-ethyl-2-pyrrolinylmethyl) -2-methoxy-5-sulfamoylbenzamide are obtained with a purity of 99.5% and a yield of 92% calculated on the ester.

Den erhållna produkten har följande egenskaper: smp = 186-l88°C; [@_7â°° = 6s,s° (c = 1 æ i omr) renhet = 99,5 %; Procentuell analys: beräknat funnet C 52,77 52,65 9 H 6,79 6,72 N 12,30 12,20The product obtained has the following properties: mp = 186-188 ° C; [@ _7â °° = 6s, s ° (c = 1 æ in omr) purity = 99.5%; Percentage analysis: calculated finding C 52.77 52.65 9 H 6.79 6.72 N 12.30 12.20

Claims (7)

10 15 20 25 30 7901337~1 PATENTKRAV10 15 20 25 30 7901337 ~ 1 PATENT REQUIREMENTS 1. l. Vänsterroterande N-(l-etyl-2-pyrrolidinylmetyl)-2- -metoxi-5-sulfamoylbensamid med följande egenskaper: smp =°ias-1ss°c, [a]â° = 68,5 (1 a i aimetyiformamia).1. 1. Left-rotating N- (1-ethyl-2-pyrrolidinylmethyl) -2- -methoxy-5-sulfamoylbenzamide having the following properties: mp = ° ias-1ss ° c, [a] â ° = 68.5 (1 ai aimetyiformamia). 2. Förfarande för framställning av lev0-N-(l-ety1- -2-pyrrolidinylmetylä-2-metoxi-5-sulfamoylbensamid, k ä n n e t e c k n a t av att levo-prolin acetyleras, den sålunda erhållna levo-N-acetyl-prolinen reduceras med en metallhydrid i ett organiskt lösningsmedel, den erhållna leve-N-etyl-2-pyrrolidinylmetanolen överföras till den motsvarande kloriden och därefter, genom om- sättning med en alkohollösning av ammoniak, till levo-N-etyl-2-metoxi-5-sulfamoylbensoat för att ge den vänsterroterande N-(l-etyl-2-pyrrolidinylmetyl)-2-met- oxi-5-sulfamoylbensamiden.Process for the preparation of levO-N- (1-ethyl--2-pyrrolidinylmethyl-2-methoxy-5-sulfamoylbenzamide, characterized in that levo-proline is acetylated, the levo-N-acetyl-proline thus obtained is reduced by a metal hydride in an organic solvent, the obtained lev-N-ethyl-2-pyrrolidinylmethanol is converted to the corresponding chloride and then, by reaction with an alcoholic solution of ammonia, to levo-N-ethyl-2-methoxy-5-sulfamoylbenzoate to give the left-rotating N- (1-ethyl-2-pyrrolidinylmethyl) -2-methoxy-5-sulfamoylbenzamide. 3. Förfarande enligt krav 2, k ä n n e t e c k n a t av att levo-prolin acetyleras med ättiksyraanhydrid i vattenlösning.3. A process according to claim 2, characterized in that levoproline is acetylated with acetic anhydride in aqueous solution. 4. Förfarande enligt krav 2, k ä n n e t e c k n a t av att N-acetyl-prolin reduceras till levo-N-etyl-2- pyrrolidinylmetanol genom uppvärmning under àterflöde med LiAlH4 i tetrahydrofuran.4. A process according to claim 2, characterized in that N-acetyl-proline is reduced to levo-N-ethyl-2-pyrrolidinylmethanol by heating under reflux with LiAlH 4 in tetrahydrofuran. 5. Förfarande enligt krav 2, k ä n n e t e c k n a t av att levo-N-etyl-2-pyrrolidinylmetanol omsättes med tionylklorid i ett klorerat organiskt lösningsmedel under kalla betingelser för att ge den motsvarande kloriden.5. A process according to claim 2, characterized in that levo-N-ethyl-2-pyrrolidinylmethanol is reacted with thionyl chloride in a chlorinated organic solvent under cold conditions to give the corresponding chloride. 6. Förfarande enligt krav 2, k ä n n e t e c k n a t av att levo-N-etyl-2-pyrrolidinyl-metylkloriden omsättes med ammoniak för att ge den motsvarande aminen.6. A process according to claim 2, characterized in that the levo-N-ethyl-2-pyrrolidinylmethyl chloride is reacted with ammonia to give the corresponding amine. 7. Förfarande enligt krav 2, k ä n n e t e c k n a t av att levo-N-etyl-2-pyrrolidinyl-metylamin omsättes med etyl-2-metoxi-5-sulfamoylbensoat i frånvaro av lösningsmedel, vid en temperatur av 80-85°C i en Z-blandare.Process according to Claim 2, characterized in that levo-N-ethyl-2-pyrrolidinylmethylamine is reacted with ethyl 2-methoxy-5-sulfamoylbenzoate in the absence of solvent, at a temperature of 80-85 ° C in a Z-mixer.
SE7901337A 1978-02-16 1979-02-15 OPTICALLY ACTIVE LEFT ROTATING N- (1-ETHYL-2-PYRROLIDINYL-METHYL) -2-METOXY-5-SULFAMOYL BENZAMIDE AND PROCEDURE TO PREPARE THIS SE430888B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20295/78A IT1095415B (en) 1978-02-16 1978-02-16 PROCESS FOR THE PRODUCTION OF AN OPTICALLY ACTIVE BENZAMIDE, OPTICALLY ACTIVE BENZAMIDE SO OBTAINED AND COMPOSITIONS

Publications (2)

Publication Number Publication Date
SE7901337L SE7901337L (en) 1979-08-17
SE430888B true SE430888B (en) 1983-12-19

Family

ID=11165504

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7901337A SE430888B (en) 1978-02-16 1979-02-15 OPTICALLY ACTIVE LEFT ROTATING N- (1-ETHYL-2-PYRROLIDINYL-METHYL) -2-METOXY-5-SULFAMOYL BENZAMIDE AND PROCEDURE TO PREPARE THIS

Country Status (15)

Country Link
JP (1) JPS54130562A (en)
AT (1) AT373870B (en)
CA (1) CA1097662A (en)
CH (1) CH639951A5 (en)
DE (1) DE2903891A1 (en)
DK (1) DK152752C (en)
EG (1) EG14440A (en)
FR (1) FR2417498A1 (en)
GB (1) GB2014990B (en)
GR (1) GR78220B (en)
IT (1) IT1095415B (en)
MX (1) MX5632E (en)
NL (1) NL190845C (en)
SE (1) SE430888B (en)
YU (1) YU41145B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1141095B (en) * 1980-11-27 1986-10-01 Ravizza Spa RESOLUTION PROCESS OF THE SULPYRID RACEMA
EP0088849A1 (en) * 1982-03-11 1983-09-21 Choay S.A. Levorotatory compounds of N-substituted benzenesulphone amides, process for their preparation and pharmaceutical compositions containing them
SE8602339D0 (en) * 1986-05-22 1986-05-22 Astra Laekemedel Ab AND EFFECTIVE STEREOCONSERVATIVE SYNTHESIS OF 1-SUBSTITUTED (S) - AND (R) -2-AMINOMETHYLPYRROLIDINES
DE4103451C2 (en) * 1991-02-02 1994-08-25 Hormosan Kwizda Gmbh Uses of the active substance sulpiride in its R or S form
WO2003055857A1 (en) * 2001-12-28 2003-07-10 Farmaceutsko-Hemijska Industrija 'zdravlje' A process for synthesis of heterocyclic aminoalkyl benzamides
ITMI20051943A1 (en) * 2005-10-14 2007-04-15 Procos Spa ANANTIOMERIC RESOLUTION PROCESS OF 2-AMINOMETHYL-PYRROLIDINES 1-SUBSTITUTED FOR DAMAGE IN THE PRESENCE OF LIPASE
CL2012000874S1 (en) 2012-01-31 2013-03-22 Saverglass Bottle with a tapered rectangular parallelepipedic body oriented vertically, with its narrowest part located at the lower end, it has all its curved edges, at its upper end it forms a rectangular surface with convex sides, which is joined to the bottle neck by means of slight slopes.
CN103772256B (en) * 2012-10-24 2017-10-10 江苏天士力帝益药业有限公司 A kind of preparation method of high-purity Sulpiride or its optical isomer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
CH605793A5 (en) * 1974-03-05 1978-10-13 Ile De France
FR2394529A2 (en) * 1977-06-13 1979-01-12 Synthelabo 2-METHOXY BENZAMIDES AND THEIR THERAPEUTIC APPLICATION
FR2393794A2 (en) * 1977-06-06 1979-01-05 Synthelabo Therapeutic 2-methoxy benzamido methyl heterocycle(s) prepn. - from 2-methoxy benzoic ester(s) and amino methyl heterocycle(s)
IL52645A (en) * 1976-08-05 1980-02-29 Synthelabo Optically active 1 substituted 2 aminomethyl pyrrolidines stereospecifics synthesis thereof and process for the preparation of optically active 2 methoxy n pyrrolidylmethyl benzamides
JPS5365875A (en) * 1976-11-24 1978-06-12 Teijin Ltd Preparation of benzenesulfone amide derivs.

Also Published As

Publication number Publication date
DE2903891A1 (en) 1979-08-23
EG14440A (en) 1984-03-31
YU30879A (en) 1983-02-28
YU41145B (en) 1986-12-31
FR2417498A1 (en) 1979-09-14
NL7901251A (en) 1979-08-20
GB2014990A (en) 1979-09-05
DK152752C (en) 1988-09-26
MX5632E (en) 1983-11-15
FR2417498B1 (en) 1983-01-21
JPS54130562A (en) 1979-10-09
CA1097662A (en) 1981-03-17
IT1095415B (en) 1985-08-10
ATA110179A (en) 1983-07-15
GR78220B (en) 1984-09-26
NL190845B (en) 1994-04-18
DK66579A (en) 1979-08-17
DK152752B (en) 1988-05-09
GB2014990B (en) 1982-06-09
CH639951A5 (en) 1983-12-15
IT7820295A0 (en) 1978-02-16
NL190845C (en) 1994-09-16
SE7901337L (en) 1979-08-17
AT373870B (en) 1984-02-27
DE2903891C2 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
US3242190A (en) 3-hydroxy-5-aminomethylisoxazole compounds
SE430888B (en) OPTICALLY ACTIVE LEFT ROTATING N- (1-ETHYL-2-PYRROLIDINYL-METHYL) -2-METOXY-5-SULFAMOYL BENZAMIDE AND PROCEDURE TO PREPARE THIS
CN116171270A (en) Preparation method of (S) -4-chloro-2-aminobutyric acid hydrochloride and (S) -4-chloro-2-aminobutyric acid ester
CN112679498B (en) Quaternary ammonium sulfonate compound and preparation method and application thereof
JPH0674243B2 (en) Optically active atenolol salt with high optical purity and process for producing atenolol
EP3524592B1 (en) Method for preparing a phenylalanine compound
CA1085420A (en) 1-aminomethyl-1-cycloalkane-acetic acid
Tipson N, N-phthaloyl-L-glutamic acid and some derivatives
US3401194A (en) Process for the resolution of stereoisomers from racemic 1-hydroxy-2-amino butane
EP0382506B1 (en) Optically active diastereomer salts of tetrahydro-2-furoic acid
EP0053584B1 (en) Raceme sulpiride resolution process
US2762841A (en) Process of producing l-glutamine
US6087499A (en) Process for producing 5-perfluoroalkyluracil derivatives
US4010160A (en) Process for the manufacture of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine
EP0293244A2 (en) N epsilon-trifluoroacetyl-L-lysyl-L-proline.D-1O-camphorsulfonic acid salt and process for producing the same
US4048169A (en) 1,3-Bis-(β-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine-naphthalene-1,5-disulphonate
EP0484742A1 (en) 2-Chloropropionaldehyde trimer and production process thereof
EP0406567A2 (en) Process for the production of sulfonium compounds and novel methylthiophenol derivatives
US3178437A (en) Process for simultaneously producing prolinols and 3-hydroxy-piperidines
KR800001178B1 (en) Process for the preparation of acetic nytriyl derivatives
JP3169681B2 (en) Method for producing 2-alkyl-4-hydroxymethylimidazole
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
CN116606238A (en) N-Boc-3-nitroindole and preparation method thereof
CN116655601A (en) Synthesis method of octreotide
CN115710213A (en) Preparation method of cis-chiral 3-fluoro-4-hydroxypiperidine and derivatives thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7901337-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7901337-1

Format of ref document f/p: F